Compounds of formula (I)
1
or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
Synthesis and activity of 1-aryl-1′-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitors
作者:Qun Li、Gary T. Wang、Tongmei Li、Stephen L. Gwaltney、Keith W. Woods、Akiyo Claiborne、Xilu Wang、Wendy Gu、Jerry Cohen、Vincent S. Stoll、Charles Hutchins、David Frost、Saul H. Rosenberg、Hing L. Sham
DOI:10.1016/j.bmcl.2004.08.011
日期:2004.11
potent and selective farnesyltransferaseinhibitors (FTIs) by transposition of the D-ring to the methyl group on the imidazole of the previously reported FTIs 3. Several compounds such as 4h and 5b demonstrate superior enzymatic activity to the current benchmark compound tipifarnib (1) with IC(50) values in the lower subnanomolar range, while maintaining excellent cellularactivity comparable to tipifarnib